Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
Clinical trial NCT00405938 · COMPLETED
Trial details
- NCT number
- NCT00405938
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2010-06-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.